• Login
    View Item 
    •   Home
    • UA Graduate and Undergraduate Research
    • Pharmacy Student Research Projects
    • View Item
    •   Home
    • UA Graduate and Undergraduate Research
    • Pharmacy Student Research Projects
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UA Campus RepositoryCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsPublisherJournalThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsPublisherJournal

    My Account

    LoginRegister

    About

    AboutUA Faculty PublicationsUA DissertationsUA Master's ThesesUA Honors ThesesUA PressUA YearbooksUA CatalogsUA Libraries

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Brentuximab Vedotin for Treatment of Non-Hodgkin Lymphomas: A Systematic Review

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Berger, Garrett
    Lawson, Stephanie
    Royball, Kelsey
    Affiliation
    College of Pharmacy, The University of Arizona
    Issue Date
    2017
    Keywords
    Non-Hodgkin Lymphoma
    Brentuximab vedotin
    Malignancies
    MeSH Subjects
    Lymphoma, Non-Hodgkin
    Brentuximab Vedotin
    Lymphoma, Large-Cell, Anaplastic
    Neoplasms
    Advisor
    McBride, Ali
    Anwer, Faiz
    
    Metadata
    Show full item record
    Rights
    Copyright © is held by the author.
    Collection Information
    This item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.
    Publisher
    The University of Arizona.
    Abstract
    Objectives: Brentuximab vedotin (BV) is an antibody-drug conjugate comprising a CD30-directed antibody conjugated to the microtubule-disrupting agent MMAE via a protease cleavable linker. BV is FDA approved for use in relapsed classical Hodgkin lymphoma and relapsed systemic Methods: primary study outcomes being objective response rate. PubMed (1946-2015), EMBASE (1947-2015), and Cochrane Central Register of Controlled Trials (1898-2015). Inclusion criteria included all studies and case reports of NHLs in which BV therapy was administered. Twenty-eight articles met these criteria. Results: Utilizing the twelve clinical subtypes, we found clinical evidence of BV and stratified the study populations into three groups: B-cell malignancies (group A), T-cell malignancies (group B), and non-B or non-T-cell hematological malignancies (group C). Across the group A malignancies, there were 87 patients. 48% experienced an objective response (OR). Across the group B malignancies, there were 274 patients. 74% experienced an OR. Across the group C malignancies, there were 9 patients. 44% experienced an OR. Conclusions: Our findings indicate that BV induces a variety of responses, largely positive and variable between NHL subtypes. With properly powered prospective studies, BV may prove to be a strong candidate in the treatment of CD30+ malignancies.
    Description
    Class of 2017 Abstract
    This project is related to the article that was later published, available at this link: https://doi.org/10.1016/j.critrevonc.2016.11.009
    Additional Links
    https://doi.org/10.1016/j.critrevonc.2016.11.009
    ae974a485f413a2113503eed53cd6c53
    https://doi.org/10.1016/j.critrevonc.2016.11.009
    Scopus Count
    Collections
    Pharmacy Student Research Projects

    entitlement

     
    The University of Arizona Libraries | 1510 E. University Blvd. | Tucson, AZ 85721-0055
    Tel 520-621-6442 | repository@u.library.arizona.edu
    DSpace software copyright © 2002-2017  DuraSpace
    Quick Guide | Contact Us | Send Feedback
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.